$5.19 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 10 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
G | GENPACT LIMITED | $1,601,262,000 | +12.4% | 57,537,264 | 0.0% | 30.86% | +16.8% | |
MIK | MICHAELS COS INC | $977,836,000 | -17.3% | 52,798,929 | 0.0% | 18.85% | -14.0% | |
Q | Sell | QUINTILES IMS HOLDINGS INC | $780,990,000 | -2.5% | 8,726,148 | -12.2% | 15.05% | +1.4% |
ATTO | ATENTO S A | $698,659,000 | +21.9% | 62,660,015 | 0.0% | 13.47% | +26.7% | |
BFAM | Sell | BRIGHT HORIZONS FAM SOL IN D | $648,792,000 | -28.6% | 8,402,956 | -32.9% | 12.50% | -25.7% |
VRTV | VERITIV CORP | $192,773,000 | -13.1% | 4,283,840 | 0.0% | 3.72% | -9.7% | |
ACHC | ACADIA HEALTHCARE COMPANY IN | $170,470,000 | +13.3% | 3,452,202 | 0.0% | 3.29% | +17.7% | |
FI | FRANKS INTL N V | $70,522,000 | -21.6% | 8,506,930 | 0.0% | 1.36% | -18.5% | |
ITGR | INTEGER HLDGS CORP | $42,482,000 | +7.6% | 982,235 | 0.0% | 0.82% | +11.9% | |
NVTRQ | NUVECTRA CORP | $4,348,000 | +94.5% | 327,411 | 0.0% | 0.08% | +104.9% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Partners VII, L.P. #6
- Bain Capital Fund VII, L.P. #7
- Bain Capital VII Coinvestment Fund, L.P. #8
- UWW Holdings, LLC #9
- Bain Capital Integral Investors 2006, LLC #10
- Bain Capital Partners Asia II, L.P. #11
- Glory Investments A Limited #12
- Glory Investments B Limited #13
- Atalaya Luxco S.a.r.l. #14
- Atalaya Luxco Topco S.C.A. #15
- Atalaya PIKco S.a.r.l. #16
- Atalaya Luxco PIKco SCA #17
- Bain Capital Partners VIII, L.P. #18
- Bain Capital Fund VIII, L.P. #19
- Bain Capital Fund VIII, LLC #20
- BC Brightness SPV GP, LLC #21
- BC Brightness SPV, LP #22
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
VERITIV CORP | 26 | Q4 2020 | 7.1% |
SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
ATENTO S A | 25 | Q4 2020 | 14.1% |
BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
4 | 2023-12-21 |
13F-HR | 2023-11-14 |
4 | 2023-10-18 |
13F-HR | 2023-08-14 |
4 | 2023-07-06 |
4 | 2023-06-12 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.